Scientific Program

  • WCLC 2018

    19th World Conference on Lung Cancer

    Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada


    Abstract Title Release: 10:00 PST, Friday August 10, 2018 (17:00 UTC)
    Full Abstract Release: 14:00 PST, Wednesday September 5, 2018 (21:00 UTC)


    Presentation Date(s):
    • Sept 23 - 26, 2018
    • Total Presentations: 2387
Filter Results:

  • +

    ISS09 - Symposium Supported by Roche: Selecting the Right Cancer Immunotherapy Regimen for the Right Patient in First-line Lung Cancer

    • 07:00 - 08:00
    • 9/25/2018
    • Moderators:
    • +

      Selecting the Right Cancer Immunotherapy Regimen for the Right Patient in First-line Lung Cancer

      07:00 - 07:00

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    ISS10 - Symposium Supported by Medscape: Progress of the NSCLC Revolution: Questioning the Experts

    • 07:00 - 08:00
    • 9/25/2018
    • Moderators:
    • +

      Progress of the NSCLC Revolution: Questioning the Experts

      07:00 - 07:00

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    ISS11 - Symposium Supported by Pfizer: Future Options for ALK+ Metastatic NSCLC

    • 07:00 - 08:00
    • 9/25/2018
    • Moderators:
    • +

      Future Options for ALK+ Metastatic NSCLC

      07:00 - 07:00

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE11 - Biology of Small Cell Lung Cancer (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Biology
    • Moderators:
    • +

      MTE11.01 - Novel Therapeutic Targets in SCLC

      07:00 - 07:30  |  Presenting Author(s): J. Sage

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE11.02 - Biological Subsets of SCLC

      07:30 - 08:00  |  Presenting Author(s): C.M. Rudin

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE12 - IO in the Real World - High Risk Populations And Patient Support (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Immunooncology
    • Moderators:
    • +

      MTE12.01 - Is IO an Option for Patients with Contraindications (Auto-immune Disease, Pulmonary Fibrosis, HIV, Hepatitis, Transplant etc)

      07:00 - 07:40  |  Presenting Author(s): A. Robinson

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE12.02 - How can we Minimize Toxicity for our High Risk Patients?

      07:40 - 08:00  |  Presenting Author(s): M. Nematollahi

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE13 - Clonal Evolution and Targeted Therapy (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Targeted Therapy
    • Moderators:
    • +

      MTE13.01 - Clonal Evolution and Targeted Therapy

      07:00 - 07:30  |  Presenting Author(s): R. Govindan

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE13.02 - Clonal Evolution and Targeted Therapy

      07:30 - 08:00  |  Presenting Author(s): J. Laskin

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE14 - Nodule Management (Pro Con Debate and Case Presentations) (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Screening and Early Detection
    • Moderators:
    • +

      MTE14.01 - Nodule Management (Pro Con Debate and Case Presentations)

      07:00 - 07:30  |  Presenting Author(s): S. Lam  |  Author(s): M. Oudkerk

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE14.02 - Nodule Management (Pro Con Debate and Case Presentations)

      07:30 - 08:00  |  Presenting Author(s): M. Oudkerk

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE15 - Who is Too High Risk for a VATS Resection? (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Treatment of Early Stage/Localized Disease
    • Moderators:
    • +

      MTE15.01 - Identifying High Risk Patients: What Makes a Patient Too High Risk for Surgery and Who Decides?

      07:00 - 07:30  |  Presenting Author(s): H. Asamura

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE15.02 - Who is Too High Risk for a VATS Resection?

      07:30 - 08:00  |  Presenting Author(s): P.E. Postmus

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE16 - What Is Changing in the Management of Pulmonary Neuroendocrine Tumours? (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Small Cell Lung Cancer/NET
    • Moderators:
    • +

      MTE16.01 - Proper Treatment of LCNEC; Chemotherapy or Targeted Therapy

      07:00 - 07:30  |  Presenting Author(s): S. Thongprasert

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

    • +

      MTE16.02 - The Management of Small Cell Lung Cancer following First Line Treatment Failure

      07:30 - 08:00  |  Presenting Author(s): G. Goss

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.

  • +

    MTE17 - Living with and Beyond Lung Cancer: An Education for Advocates (Ticketed Session)

    • 07:00 - 08:00
    • 9/25/2018
    • Type: Meet the Expert
    • Track: Advocacy
    • Moderators:
    • +

      MTE17.01 - Living with and Beyond Lung Cancer: An Education for Advocates

      07:00 - 08:00  |  Presenting Author(s): W. Boerckel, M. Rigney  |  Author(s): A. McNamara

      • Abstract

      The abstract for this presentation will be made available at 21:00 UTC on September 5, 2018 (14:00 Pacific Daylight Time) unless it’s a part of the press program. Presentations selected for the WCLC press program are embargoed until the start of their presentation at the WCLC or their presentation in a press conference, whichever comes first. Please return after this date to review more information about this presentation.